Therapies for psoriatic nail disease. A systematic review

Journal of Rheumatology

Volumn 33, Issue 7, 2006, Pages 1452-1456

  Cassell, Sarah ^a   Kavanaugh, Arthur F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Nail; Psoriasis; Psoriatic arthritis; Treatment

Indexed keywords

ALEFACEPT; BELANYX; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CYCLOSPORIN A; DITHRANOL; ETRETINATE; FLUOROURACIL; INFLIXIMAB; METHOXSALEN; NIMESULIDE; PROPYLENE GLYCOL; RETINOID; SALICYLIC ACID; STEROID; TAZAROTENE; TRIAMCINOLONE ACETONIDE; UREA;

CLINICAL TRIAL; ELECTRON THERAPY; EVIDENCE BASED MEDICINE; HUMAN; MEDLINE; META ANALYSIS; NAIL DISEASE; ONYCHOLYSIS; OUTCOME ASSESSMENT; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUVA; QUALITY OF LIFE; RADIOTHERAPY; REVIEW; SYSTEMATIC REVIEW; TOPICAL TREATMENT;

ARTHRITIS, PSORIATIC; DRUG THERAPY; DRUG TOXICITY; HUMANS; NAIL DISEASES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33745790063     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. de Berker D. Management of nail psoriasis. Clin Exp Dermatol 2000;25:357-62.
2. Gladman DD, Anhorn KB, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
3. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails is associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology 1996;193:300-3.
4. Habif TP. Clinical dermatology. 4th ed. New York: Mosby Inc.; 2004.
5. Omura EF. Histopathology of the nail. Dermatol Clin 1985;3:531-41.
6. Zaias N. Psoriasis of the nail: a clinical-pathologic study. Arch Dermatol 1969;99:567-79.
7. Achten G, Parent D. The normal and pathologic nail. Int J Dermatol 1983;22:556-65.
8. Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003;49:206-12.
9. Piraccini BM, Tosti A, Iorizzo M, Misciali C. Pustular psoriasis of the nails: treatment and long-term follow-up of 46 patients. Br J Dermatol 2001;144:1000-5.
10. Tosti A, Piraccini BM, Cameli N, et al. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998;139:655-9.
11. Rigopoulos D, Ioannides D, Prastitis N, Katsambas A. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream [letter]. Acta Derm Venereol 2002;82:140.
12. Scher RK, Stiller M, Zhu YI. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 2001;68:355-8.
13. Bianchi L, Soda R, Diluvio L, Chimenti S. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br J Dermatol 2003;149:1207-9.
14. Fredriksson T. Topically applied fluorouracil in the treatment of psoriatic nails. Arch Dermatol 1974;110:735-6.
15. de Jong EM, Menke HE, van Praag MCG, van de Kerkhof PC. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. Dermatology 1999;199:313-8.
16. Yamamoto T, Katayama I, Nishioka K. Topical anthralin therapy for refractory nail psoriasis. J Dermatol 1998;25;231-3.
17. Reich K, Nestle FO, Papp K, et al. Infliximab induction and maintenance therapy for moderate to severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005;366:1367-74.
18. Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S. Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 2005;52:736-7.
19. Cassetty CT, Alexis AF, Shupack IL, Strober BE. Alefacept in the treatment of psoriatic nail disease: a small case series. J Am Acad Dermatol 2005;52:1101-2.
20. Feliciani C, Zampetti A, Forleo P, et al. Nail psoriasis: combined therapy with systemic cyclosporine and topical calcipotriol. J Cutan Med Surg 2004;8:122-5.
21. Mahrle G, Schulze HI, Farber L, Weidinger G, Steigleder GK. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail and joint involvement. J Am Acad Dermatol 1995;32:78-88.
22. Abell E. Treatment of psoriatic nail dystrophy. Br J Dermatol 1972;86:79-82.
23. Abell E, Samman PD. Intradermal triamcinolone treatment of nail dystrophies. Br J Dermatol 1973;89:191-7.
24. Peachey RD, Pye RJ, Harman RR. The treatment of psoriatic nail dystrophy with intradermal steroid injections. Br J Dermatol 1976;95:75-8.
25. Bleeker JJ. Intradermal triamcinolone acetonide treatment of psoriatic nail dystrophy with Port-O-Jet [letter]. Br J Dermatol 1975;92:479.
26. Bedi TR. Intradermal triamcinolone treatment of psoriatic onychodystrophy. Dermatologica 1977;155:24-7.
27. de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998;138:90-5.
28. Bleeker JJ. Intralesional triamcinolone acetonide using the Port-O-Jet and needle injections in localized dermatoses. Br J Dermatol 1974;91:97-101.
29. Marx JL, Scher RK. Response of psoriatic nails to oral photochemotherapy. Arch Dermatol 1980;116:1023-4.
30. Cannavo SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B. Treatment of psoriatic nails with topical cyclosporine: a prospective randomized placebo-controlled study. Dermatology 2003;206:153-6.
31. Kwang TY, Nee TS, Seng KT. A therapeutic study of nail psoriasis using electron beams [letter]. Acta Derm Venereol 1995;75:90.
32. Lindelof B. Psoriasis of the nails treated with grenz rays: a double-blind bilateral trial. Acta Derm Venereol 1989;69:80-2.
33. Yu RC, King CM. A double-blind study of superficial radiotherapy in psoriatic nail dystrophy. Acta Derm Venereol 1992;72:134-6.
34. Cassell S, Tutuncu Z, Lee SJ, et al. Assessment of nail involvement in psoriatic arthritis (PsA): development and validation of a modified Nail Psoriasis Severity Index (NAPSI) [abstract]. Arthritis Rheum 2005;52 Suppl:4076.